Eindhoven and ‘s-Hertogenbosch, July 8, 2024 – ECFG (through its investment fund ECFG Ventures III) has acquired a minority stake in Mint Solutions Holding BV (MedEye).

This is already the second participation in this third fund of the Eindhoven-based VC investor. MedEye provides nurses with tools that enable them to automatically verify and record medication at the patient’s bedside. This is done through smart hardware and software solutions. MedEye is the only solution on the market specializing in administration verification and is already active in various nursing homes and Dutch (top clinical) hospitals such as CWZ, Zuyderland, and Haga Hospital. The capital injection allows MedEye to expand to Scandinavia and Belgium, where the first hospitals and care institutions are now being connected.

A revolution in medication safety
Before a medication reaches the patient, various information and physical transfers take place in the hospital. This complexity sometimes leads to errors. Fortunately, not all errors result in patient injury, but checking the correct medication, dosage, patient data, and time of administration is of great importance. Half of all medication errors can be stopped at the moment of administration to the patient. Where hospitals and healthcare institutions struggle with staff shortages, MedEye can offer a solution with its smart tooling. MedEye simplifies the nursing workflow, automatically checks and records all medications, and saves nurses time.

Capitalizing on international opportunities
ECFG is a hands-on investor focusing on technological, innovative scale-ups. ECFG offers advice, guidance, knowledge, and capital, enabling companies to focus on further growth and value creation. “We like to invest in companies that offer hardware solutions in addition to software. We have built our expertise here, and this aligns seamlessly with the strength of the Brainport region. MedEye is an interesting addition to our portfolio because it has proven to offer a unique solution to a very urgent and international problem,” says Leo van Schijndel, Investment Director at ECFG.3 “In the Netherlands, MedEye can rely on a solid foundation, and the products have proven themselves. This provides a solid basis for further expansion in other Western European countries. In addition to the necessary capital, we offer the experienced management team the structure and tools to capitalize on these international opportunities.”

Accelerating growth
“In these times of acute staff shortages in healthcare, we see a rapidly growing need for tools to support nursing staff while minimizing the margin of error. MedEye’s technology fulfills this need and is generating increasing interest from the healthcare sector. With ECFG as an investment partner, we are enabled to roll out our unique product to a larger target group and in larger volumes, not only within the Netherlands but also internationally. With this, MedEye is entering a new growth phase with an ambitious goal. We look forward to taking great steps together with the ECFG team,” says Gauti Reynisson, CEO of MedEye.